Reporte zur Charge OEN8732

Symptomtext

Body pain; Low fever; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: OEN8732) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Patient had no relevant medical history. Patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not received any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN 6206) via an unspecified route of administration in the left arm on 11Mar2021 at 15:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 13:45, the patient experienced low grade fever and body pain. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events of low grade fever and general body pain was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.